Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies

Humans and laboratory animals recognize human modified LDL as immunogenic. Immune complexes (ICs) isolated from human sera contain malondialdehyde-modified LDL (MDA-LDL) and N ε(carboxymethyl)lysine-modified LDL (CML-LDL) as well as antibodies reacting with MDA-LDL, copper-oxidized LDL (OxLDL), CML-...

Full description

Bibliographic Details
Main Authors:	Gabriel Virella, Suzanne R. Thorpe, Nathan L. Alderson, M. Brooks Derrick, Charlyne Chassereau, J. Matthew Rhett, Maria F. Lopes-Virella
Format:	Article
Language:	English
Published:	Elsevier 2004-10-01
Series:	Journal of Lipid Research
Subjects:	low density lipoprotein modifications low density lipoprotein autoantibodies modified low density lipoprotein antibodies immunology of atherosclerosis autoimmunity atherosclerosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520312591

Similar Items

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages
by: Antonio F. Saad, et al.
Published: (2006-09-01)

Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population
by: Francisco J. Tinahones, et al.
Published: (2005-03-01)

Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia[S]
by: Elizabeth A. O'Hare, et al.
Published: (2014-11-01)

Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
by: Gunilla Nordin Fredrikson, et al.
Published: (2006-09-01)

Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages
by: Yuchang Fu, et al.
Published: (2000-12-01)

Metabolic origins and clinical significance of LDL heterogeneity
by: Kaspar K. Berneis, et al.
Published: (2002-09-01)

How realistic are the LDL-C targets in new dyslipidemia guidelines - is it possible to reach the targets?
by: Barış Güngör
Published: (2020-03-01)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
by: Feroz Ahmad, et al.
Published: (2021-09-01)

Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells
by: Evelyn E. Griffin, et al.
Published: (2005-10-01)

Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase
by: Riia Plihtari, et al.
Published: (2010-07-01)

Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic
by: Hsin-hung Chen, et al.
Published: (2007-01-01)

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
by: Danijela Lucic, et al.
Published: (2007-02-01)

Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid
by: Rebecca A. Patterson, et al.
Published: (2003-03-01)

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9
by: Holly E. Careskey, et al.
Published: (2008-02-01)

The lack of association between different LDL‐C levels and oxidized LDL in patients with type 2 diabetes
by: Soghra Rabizadeh, et al.
Published: (2023-12-01)

LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans
by: C. Charles Michel, et al.
Published: (2015-01-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

ApoE genotype-specific inhibition of apoptosis
by: Robert M. DeKroon, et al.
Published: (2003-08-01)

Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL[S]
by: Naoko Sawada, et al.
Published: (2020-06-01)

Measurment of rhesus monkey (Macaca mulatta) apolipoprotein B in serum by radioimmunoassay: comparison of immunoreactivities of rhesus and human low density lipoproteins
by: J B Karlin, et al.
Published: (1978-02-01)

Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
by: Rene C. Adam, et al.
Published: (2020-09-01)

The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis[S]
by: Yu-Xin Xu, et al.
Published: (2015-02-01)

Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes[S]
by: Ying Zhang, et al.
Published: (2016-02-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

High-density lipoproteincholesterol, reverse cholesterol transport, and cardiovascular risk: a tale of genetics?
by: Giovanni Cimmino, et al.
Published: (2013-10-01)

Lysosomal oxidation of LDL alters lysosomal pH, induces senescence, and increases secretion of pro-inflammatory cytokines in human macrophages[S]
by: Feroz Ahmad, et al.
Published: (2019-01-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
by: Susan J. Murdoch, et al.
Published: (2002-08-01)

Cholesterol loading in macrophages stimulates formation of ER-derived vesicles with elevated ACAT1 activity
by: Naomi Sakashita, et al.
Published: (2010-06-01)

The early years of lipoprotein research: from discovery to clinical application
by: Patty W. Siri-Tarino, et al.
Published: (2016-10-01)

Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice
by: A.C. Casquero, et al.
Published: (2006-07-01)

Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia
by: Joan Carles Escolà-Gil, et al.
Published: (2000-08-01)

Lipoprotein aggregation protects human monocyte-derived macrophages from OxLDL-induced cytotoxicity
by: Reto Asmis, et al.
Published: (2005-06-01)

Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E
by: Kenneth C-W. Yu, et al.
Published: (2000-11-01)

Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis
by: Timothy J. Sontag, et al.
Published: (2015-02-01)

Thematic review series: Patient-Oriented Research. What we have learned about VLDL and LDL metabolism from human kinetics studies
by: Klaus G. Parhofer, et al.
Published: (2006-08-01)

Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mices⃞
by: Stefan P.J. Dullens, et al.
Published: (2008-04-01)

Effect of fluid mechanical stresses and plasma constituents on aggregation of LDL
by: Roy M. Talbot, et al.
Published: (2003-04-01)

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
by: Juha Vakkilainen, et al.
Published: (2002-04-01)

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism
by: John S. Millar, et al.
Published: (2008-03-01)